NUVB - Nuvation Bio Stock Quotes

The daily price chart for Nuvation Bio Inc. (NUVB) reflects the dynamics of a biotech company developing cancer treatments. The asset is subject to volatility due to a lack of profitability and dependence on trial results, with the metric standing at 3.98. Quotes rely on hopes for drug approvals, as sales are currently non-existent. Business resilience is currently determined solely by the volume of available reserves prior to market entry.

Nuvation Corp - NUVB Price Chart (period 07/04/2022 - 11/15/2026)

NUVB (Nuvation Pharma): analytical breakdowns and indicator data

- stock value and consensus price forecast:

Price Chart Nuvation Pharma|NUVB - Broker Consensus Forecast

- market capitalization statistics:

Market Valuation Nuvation Pharma|NUVB - Enterprise Value

- issuer book value statistics:

Accounting Value per Share Nuvation Bio|NUVB - Company Book Value|Market Capitalization to Book Value Ratio nuvationbio.com|NUVB - Aggregate Company Assets

- company liabilities and liquidity data:

- financial results and valuation multiples details:

NUVB - Final Profit|Projected Future Earnings Nuvation Bio Inc.|NUVB - P/E Multiple|Future Price to Earnings Nuvation Pharma|NUVB - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Nuvation Bio|NUVB - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Nuvation Bio|NUVB - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months nuvationbio.com|NUVB - Earnings per share growth this year|Earnings growth forecast for next year Nuvation Bio Inc.

- issuer revenue and sales details:

NUVB - Company Sales|Company Projected Revenue Nuvation Corp|NUVB - Price to Sales|Price-to-Projected Revenue Ratio Nuvation Corp|NUVB - Sales Growth YoY (Last Twelve Months)

Analysis of all company metrics:NUVB Nuvation Pharma

Price action reacts sharply to the publication of clinical data and quarterly reports. This indicator measures the current market capitalization of a single share, reflecting aggregate investor expectations. For Nuvation Bio Inc. (NUVB), this serves as a metric for the effective implementation of its strategy to build a diversified oncology portfolio. The management's resource base directly impacts the asset's investment attractiveness. The final change in exchange value visualizes the long-term development vector of the business.

Who Nuvation Bio Inc. competes with